{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T20:22:59Z","timestamp":1776025379237,"version":"3.50.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,19]]},"abstract":"<jats:p>Bladder cancer (BC) is fatal during muscle invasion and treatment progress is limited. In this study, we aimed to construct and validate basement membrane (BM)-associated gene prognosis to predict BC progression and tumor immune infiltration correlation. We choreographed BM-related genes in the Cancer Genome Atlas (TCGA) database using COX regression and least absolute shrinkage and selection operator (LASSO) analysis, and the predictive value of BM-related genes was further validated by the GSE32548, GSE129845, and immunohistochemistry staining. All analyses were performed with R-version 4.2.2, and its appropriate packages. Three genes were identified to construct a gene signature to predictive of BC prognosis. We divided the TCGA database into 2 groups, and patients in the high-risk group had worse overall survival (OS) than those in the low-risk group. In GSE32548, we confirmed that patients in the high-risk group had a poorer prognosis compared to those in the low-risk group in terms of OS. Immunohistochemical staining of EPEMP1, GPC2, and ITGA3 showed significantly higher expression at the protein level in BC tissues than in normal tissues. The Spearman analysis showed risk score was positively correlated with B cell na\u00efve, Macrophages M2, and Mast cells resting. stromal score, immune score, and ESTIMATE scores were significantly higher in the high-risk group. drugs sensitivity analysis showed IC50 of Cisplatin, Gemcitabine, and Methotrexate in the high-risk group was significantly higher than that in the low-risk group. We identified 3 prognostic genes from a novel perspective of BM genes as effective risk stratification tools for BC patients.<\/jats:p>","DOI":"10.1097\/md.0000000000038858","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:14:29Z","timestamp":1721434469000},"page":"e38858","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Identification and validation of basement membrane-related genes predicting prognosis and immune infiltration associated with bladder cancer"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8848-3304","authenticated-orcid":false,"given":"Fie","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Urology Surgery, Chengdu Second People\u2019s Hospital, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chengdu Second People\u2019s Hospital, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thongher","family":"Lia","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Chengdu Second People\u2019s Hospital, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Chengdu Second People\u2019s Hospital, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyou","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Chengdu Second People\u2019s Hospital, Chengdu, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAP.0000000000000252","article-title":"Updates on the genomics of bladder cancer and novel molecular taxonomy.","volume":"27","author":"Al-Ahmadie","year":"2020","journal-title":"Adv Anat Pathol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.gendis.2022.07.002","article-title":"Identification of new aptamer BC-3 targeting RPS7 from rapid screening for bladder carcinoma.","volume":"10","author":"Liu","year":"2023","journal-title":"Genes Dis"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"207","DOI":"10.32604\/or.2023.028163","article-title":"A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu\u00e9rin in patients with non-muscle invasive bladder carcinoma: a retrospective study.","volume":"31","author":"Villoldo","year":"2023","journal-title":"Oncol Res"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41585-020-00404-6","article-title":"Defining cisplatin eligibility in patients with muscle-invasive bladder cancer.","volume":"18","author":"Jiang","year":"2021","journal-title":"Nat Rev Urol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.gendis.2023.03.031","article-title":"Echinatin inhibits tumor growth and synergizes with chemotherapeutic agents against human bladder cancer cells by activating p38 and suppressing Wnt\/\u03b2-catenin pathways.","volume":"11","author":"Wang","year":"2024","journal-title":"Genes Dis"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","article-title":"Molecular and histopathology directed therapy for advanced bladder cancer.","volume":"16","author":"Alifrangis","year":"2019","journal-title":"Nat Rev Urol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020.","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R8-20250503","first-page":"44","article-title":"Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition).","volume":"9","author":"Jin","year":"2022","journal-title":"Mil Med Res"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.matbio.2021.11.003","article-title":"The basement membrane in the cross-roads between the lung and kidney.","volume":"105","author":"Jandl","year":"2022","journal-title":"Matrix Biol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12015-011-9278-y","article-title":"Basement membrane matrix (BME) has multiple uses with stem cells.","volume":"8","author":"Arnaoutova","year":"2012","journal-title":"Stem Cell Rev Rep"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/nu14010032","article-title":"Curcumin may prevent basement membrane disassembly by matrix metalloproteinases and progression of the bladder cancer.","volume":"14","author":"Wro\u0144ski","year":"2021","journal-title":"Nutrients"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1073\/pnas.1118910109","article-title":"Mechanical compression drives cancer cells toward invasive phenotype.","volume":"109","author":"Tse","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"e38863","DOI":"10.1371\/journal.pone.0038863","article-title":"Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.","volume":"7","author":"Lindgren","year":"2012","journal-title":"PLoS One"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1681\/ASN.2019040335","article-title":"Single-cell transcriptomic map of the human and mouse bladders.","volume":"30","author":"Yu","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: an update.","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1016\/j.gendis.2022.10.022","article-title":"A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells.","volume":"10","author":"Wang","year":"2023","journal-title":"Genes Dis"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1002\/jcp.26916","article-title":"Cancer stem cells as a therapeutic target in bladder cancer.","volume":"234","author":"Aghaalikhani","year":"2019","journal-title":"J Cell Physiol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.odw.2013.01.040","article-title":"Gene evolution and functions of extracellular matrix proteins in teeth.","volume":"72","author":"Yoshizaki","year":"2013","journal-title":"Orthod Waves"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.ctdb.2018.02.005","article-title":"Basement membranes in development and disease.","volume":"130","author":"Sekiguchi","year":"2018","journal-title":"Curr Top Dev Biol"},{"key":"R20-20250503","first-page":"9826484","article-title":"Electrochemical evaluation of tumor development via cellular interface supported CRISPR\/Cas trans-cleavage.","volume":"2022","author":"Cheng","year":"2022","journal-title":"Research (Wash D C)"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1083\/jcb.143.6.1749","article-title":"Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells.","volume":"143","author":"O\u2019Connor","year":"1998","journal-title":"J Cell Biol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/genes12060872","article-title":"Utility of EFEMP1 in the prediction of oncologic outcomes of urothelial carcinoma.","volume":"12","author":"Chen","year":"2021","journal-title":"Genes (Basel)"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2010.11.004","article-title":"EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo.","volume":"121","author":"Song","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"857308","DOI":"10.3389\/fimmu.2022.857308","article-title":"GPC2 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer.","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12967-018-1637-x","article-title":"Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer.","volume":"16","author":"Xu","year":"2018","journal-title":"J Transl Med"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"100344","DOI":"10.1016\/j.xcrm.2021.100344","article-title":"A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope.","volume":"2","author":"Raman","year":"2021","journal-title":"Cell Rep Med"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12876-020-01560-0","article-title":"Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11010-020-03835-2","article-title":"Interference with circBC048201 inhibits the proliferation, migration, and invasion of bladder cancer cells through the miR-1184\/ITGA3 axis.","volume":"474","author":"Jiang","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"658547","DOI":"10.3389\/fonc.2021.658547","article-title":"ITGA3 is associated with immune cell infiltration and serves as a favorable prognostic biomarker for breast cancer.","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cas.12842","article-title":"Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3\/ITGB1 signaling in prostate cancer.","volume":"107","author":"Kurozumi","year":"2016","journal-title":"Cancer Sci"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"843077","DOI":"10.3389\/fimmu.2022.843077","article-title":"Molecular characteristics, clinical significance, and cancer immune interactions of angiogenesis-associated genes in gastric cancer.","volume":"13","author":"Qing","year":"2022","journal-title":"Front Immunol"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"934928","DOI":"10.3389\/fonc.2022.934928","article-title":"A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1038\/s41388-021-02019-6","article-title":"CD8(+) T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer.","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.7150\/thno.53649","article-title":"Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.","volume":"11","author":"Hu","year":"2021","journal-title":"Theranostics"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"725223","DOI":"10.3389\/fimmu.2021.725223","article-title":"A robust hypoxia risk score predicts the clinical outcomes and tumor microenvironment immune characters in bladder cancer.","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","article-title":"Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression.","volume":"25","author":"Segovia","year":"2019","journal-title":"Nat Med"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(17)30007-4","article-title":"Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study.","volume":"18","author":"Plimack","year":"2017","journal-title":"Lancet Oncol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"e002917","DOI":"10.1136\/jitc-2021-002917","article-title":"Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.","volume":"9","author":"Zhu","year":"2021","journal-title":"J ImmunoTher Cancer"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma.","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.21873\/anticanres.11004","article-title":"Extracellular matrix-dependent pathways in colorectal cancer cell lines reveal potential targets for anticancer therapies.","volume":"36","author":"Stankevicius","year":"2016","journal-title":"Anticancer Res"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s11658-019-0162-0","article-title":"Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.","volume":"24","author":"Bao","year":"2019","journal-title":"Cell Mol Biol Lett"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.gene.2017.05.054","article-title":"Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer.","volume":"626","author":"Wu","year":"2017","journal-title":"Gene"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"119984","DOI":"10.1016\/j.lfs.2021.119984","article-title":"Crosstalk between miRNA and PI3K\/AKT\/mTOR signaling pathway in cancer.","volume":"285","author":"Akbarzadeh","year":"2021","journal-title":"Life Sci"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1158\/1078-0432.CCR-21-1943","article-title":"Activation of PI3K\/AKT pathway is a potential mechanism of treatment resistance in small cell lung cancer.","volume":"28","author":"Jin","year":"2022","journal-title":"Clin Cancer Res"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1574892816666210201120324","article-title":"Effect of PI3K\/AKT\/mTOR signaling pathway on regulating and controlling the anti-invasion and metastasis of hepatoma cells by bufalin.","volume":"16","author":"Sheng","year":"2021","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"106069","DOI":"10.1016\/j.biocel.2021.106069","article-title":"lncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K\/AKT\/mTOR signaling pathway.","volume":"140","author":"Yang","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer.","volume":"41","author":"Chi","year":"2022","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:31:55Z","timestamp":1746318715000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":47,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038858","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]}}}